A novel immune regulatory peptide, PEPITEM (peptide inhibitor of trans-endothelial migration), controls T-cell trafficking during inflammation, a tonic inhibitory pathway that is lost in Type 1 diabetes

M. Chimen, H. M. McGettrick, C. M. Yates, A. Kennedy, A. Martin, F. Barone, L. S. K. Walker, C. D. Buckley, G. B. Nash, G. E. Rainger, P. Narendran

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)46-46
Number of pages1
JournalDiabetic Medicine
Volume31
Issue numberSupp 1
Publication statusPublished - Mar 2014

Cite this